In case you didn't see the recent news, I wanted to share MSAA's news article about FDA approval for the first generic versions of Gilenya® (fingolimod) oral capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients - here is the full link from the website:
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.